Avitide Revenue and Competitors
Estimated Revenue & Valuation
- Avitide's estimated annual revenue is currently $5.7M per year.
- Avitide's estimated revenue per employee is $155,000
Employee Data
- Avitide has 37 Employees.
- Avitide grew their employee count by 0% last year.
Avitide's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer/Founder | Reveal Email/Phone |
2 | Chief Financial Officer and VP Operations | Reveal Email/Phone |
3 | vp technology development | Reveal Email/Phone |
4 | VP Commercial Supply Operations | Reveal Email/Phone |
5 | Director, Downstream Development | Reveal Email/Phone |
6 | Associate Scientist | Reveal Email/Phone |
7 | Associate Scientist | Reveal Email/Phone |
8 | Scientist | Reveal Email/Phone |
9 | Scientist | Reveal Email/Phone |
10 | Lead Scientist | Reveal Email/Phone |
Avitide Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.5M | 68 | 1% | N/A | N/A |
#2 | $4.3M | 28 | 4% | N/A | N/A |
#3 | $2M | 13 | 8% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $3.7M | 24 | -11% | N/A | N/A |
#6 | $1.1M | 7 | 0% | N/A | N/A |
#7 | $45.3M | 292 | -9% | N/A | N/A |
#8 | $1.4M | 9 | 0% | N/A | N/A |
#9 | $2M | 13 | 8% | N/A | N/A |
#10 | $7M | 45 | -34% | N/A | N/A |
What Is Avitide?
Avitide discovers, develops, manufactures and supplies custom and catalog biopharmaceutical affinity purification solutions to the biopharmaceutical industry. Avitide's proprietary AVIPureâ„¢ affinity ligand portfolio sets the standard for precise affinity separations and consistent robust performance for its high-valued chromatographic products. Avitide develops these technologies with an industry-leading 3-month, concept to resin delivery service timeline that enables industry biopharmaceutical manufacturers and contract developers to achieve faster bioprocess development timelines, improved process economics, predictable scalability, and enable next-generation integrated continuous downstream processing. Avitide's commercial resin manufacturing and supply operates under an ISO 9001:2015 quality management system and has been successfully audited for its quality systems and continuity of supply plan for its affinity chromatography products. Avitide has successfully deployed affinity purification technologies towards an array of biological molecules including enzymes, bispecific antibodies, therapeutic scaffolds, growth factors, hormones, insulins, blood factors, Fcfusions, cell-based therapies, vaccines, and gene therapy viral vectors. Avitide's management team brings substantial industry expertise and a successful track record in commercializing innovative biopharmaceutical manufacturing platforms. Avitide is financed by premier venture capital and private equity firms, including Polaris Venture Partners, OrbiMed Advisors, Mithril Capital Management, Sands Capital Ventures, Section 32, SV Health Investors, Borealis Ventures, and NeoMed Management. For more information, visit www.avitide.com.
keywords:N/AN/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 37 | 6% | N/A |
#2 | $35M | 38 | 12% | N/A |
#3 | $7.7M | 39 | 5% | N/A |
#4 | $10.5M | 40 | 5% | N/A |
#5 | $8.6M | 40 | 3% | N/A |